Abstract
The evolutionarily conserved and developmentally important Wnt signaling pathway has traditionally been regarded as a critical player in tumorigenesis through the canonical Wnt/β-catenin cascade. Nevertheless, accumulating evidence based on recent research has revealed the previously unacknowledged role of noncanonical Wnt/planar cell polarity (PCP) signaling in cancer progression, invasion and metastasis, and angiogenesis. This review describes the PCP signaling pathway and its ever-expanding components and modulators, highlights the most recent studies that provide insight into the link between PCP signaling and cancer, and, finally, proposes a model by which PCP signaling may promote cancer development. This review underscores the emerging theme that deregulated PCP signaling contributes to tumorigenesis, providing new potential targets for cancer therapy. Copyright © 2009 American Association for Cancer Research.
Cite
CITATION STYLE
Wang, Y. (2009, August 1). Wnt/Planar cell polarity signaling: A new paradigm for cancer therapy. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.MCT-09-0282
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.